Last $163.21 USD
Change Today +0.32 / 0.20%
Volume 724.3K
ALXN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Leonard Bell M.D.

Co-Founder, Chief Executive Officer, Treasurer and Director, Alexion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 2 different industries.

See Board Relationships
56$13,388,704
As of Fiscal Year 2013

Background*

Dr. Leonard Bell, MD, Co-Founded Alexion Pharmaceuticals, Inc. and has been its Chief Executive Officer and Treasurer since January 1992. Dr. Bell served as Secretary of Alexion Pharmaceuticals, Inc. since 1992. From January 1992 to March 2002, Dr. Bell also served as the President of Alexion Pharmaceuticals, Inc. He has been a Director of Alexion Pharmaceuticals, Inc., since February 1992. He serves as a Director of Connecticut United for Research Excellence, Inc. He ...

Read Full Background

Corporate Headquarters*

352 Knotter Drive
Cheshire, Connecticut 06410

United States

Phone: 203-272-2596
Fax: 203-271-8198

Board Members Memberships*

1992-Present
Co-Founder, Chief Executive Officer, Treasurer and Director
2000-N/A
Former Director

Education*

BA
Brown University
MD
Yale University School Of Medicine

Other Affiliations*

Annual Compensation*

Salary$1,200,000
Total Annual Compensation$1,200,000

Stock Options*

Restricted Stock Awards$4,270,038
All Other Compensation$17,654
Exercised Options180,664
Exercised Options Value$21,844,933
Exercisable Options2,073,417
Exercisable Options Value$222,345,755
Unexercisable Options498,045
Unexercisable Options Value$30,768,616
Total Value of Options$274,959,304
Total Number of Options2,752,126

Total Compensation*

Total Annual Cash Compensation$3,617,654
Total Short Term Compensation$1,200,000
Other Long Term Compensation$4,287,692
Total Calculated Compensation$13,388,704
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $163.21 USD +0.32

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Martine A. Rothblatt Ph.D., J.D., MBAFounder, Chairman and Chief Executive Officer
United Therapeutics Corporation
$992.7K
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
Simon E. Moroney Ph.D.Chairman of Management Board and Chief Executive Officer
Morphosys AG
€772.6K
Randal J. Kirk J.D.Chairman, Chief Executive Officer and President
Intrexon Corporation
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.